The price-to-earnings ratio for Becton Dickinson & Co. (NYSE: BDX) is above average at 57.17x, Company’s 36-month beta value is 0.44.Analysts have differing opinions on the stock, with 3 analysts rating it as a “buy,” 7 as “overweight,” 5 as “hold,” and 0 as “sell.”
The public float for BDX is 288.49M, and currently, short sellers hold a 0.97% ratio of that floaft. The average trading volume of BDX on April 09, 2024 was 1.44M shares.
BDX) stock’s latest price update
Becton Dickinson & Co. (NYSE: BDX)’s stock price has plunge by -1.81relation to previous closing price of 246.17. Nevertheless, the company has seen a -0.95% plunge in its stock price over the last five trading sessions. Zacks Investment Research reported 2024-04-08 that The latest worldwide commercial availability of BD’s (BDX) cell sorters is set to expand researchers’ capabilities to transform research and cell-based therapeutic development across numerous fields.
BDX’s Market Performance
BDX’s stock has fallen by -0.95% in the past week, with a monthly rise of 1.73% and a quarterly drop of -0.15%. The volatility ratio for the week is 1.65% while the volatility levels for the last 30 days are 1.66% for Becton Dickinson & Co. The simple moving average for the past 20 days is 0.11% for BDX’s stock, with a -4.15% simple moving average for the past 200 days.
Analysts’ Opinion of BDX
Many brokerage firms have already submitted their reports for BDX stocks, with Raymond James repeating the rating for BDX by listing it as a “Outperform.” The predicted price for BDX in the upcoming period, according to Raymond James is $305 based on the research report published on July 24, 2023 of the previous year 2023.
Morgan Stanley, on the other hand, stated in their research note that they expect to see BDX reach a price target of $295. The rating they have provided for BDX stocks is “Overweight” according to the report published on May 30th, 2023.
Piper Sandler gave a rating of “Overweight” to BDX, setting the target price at $290 in the report published on May 05th of the previous year.
BDX Trading at 0.67% from the 50-Day Moving Average
After a stumble in the market that brought BDX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -15.87% of loss for the given period.
Volatility was left at 1.66%, however, over the last 30 days, the volatility rate increased by 1.65%, as shares surge +0.76% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +2.18% upper at present.
During the last 5 trading sessions, BDX fell by -0.95%, which changed the moving average for the period of 200-days by -6.06% in comparison to the 20-day moving average, which settled at $241.54. In addition, Becton Dickinson & Co. saw -0.87% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at BDX starting from Spoerel Thomas J, who sale 282 shares at the price of $238.29 back on Mar 14 ’24. After this action, Spoerel Thomas J now owns 2,276 shares of Becton Dickinson & Co., valued at $67,198 using the latest closing price.
Garrison Michael David, the EVP & President Medical of Becton Dickinson & Co., sale 1,239 shares at $232.46 during a trade that took place back on Dec 11 ’23, which means that Garrison Michael David is holding 7,274 shares at $288,018 based on the most recent closing price.
Stock Fundamentals for BDX
Current profitability levels for the company are sitting at:
- 0.1 for the present operating margin
- 0.41 for the gross margin
The net margin for Becton Dickinson & Co. stands at 0.06. The total capital return value is set at 0.04. Equity return is now at value 5.13, with 2.47 for asset returns.
Based on Becton Dickinson & Co. (BDX), the company’s capital structure generated 0.39 points at debt to capital in total, while cash flow to debt ratio is standing at 0.21. The debt to equity ratio resting at 0.64. The interest coverage ratio of the stock is 8.19.
Currently, EBITDA for the company is 4.71 billion with net debt to EBITDA at 3.77. When we switch over and look at the enterprise to sales, we see a ratio of 4.35. The receivables turnover for the company is 8.6for trailing twelve months and the total asset turnover is 0.37. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.08.
Conclusion
In a nutshell, Becton Dickinson & Co. (BDX) has experienced a bad performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
